Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02754570 · ClinicalTrials.gov registry record · NA
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02754570 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 27 participants.
The verdict
NCT02754570, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The aim of this study will be to determine the effects of pilocarpine as an adjunct medication to latanoprost monotherapy at multiple intervals throughout a 24-hour period and compare these effects to latanoprost alone.
Interventions
- DRUG Pilocarpine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02754570
The ClinicalTrials.gov registry entry for NCT02754570 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pilocarpine is the first listed.
NCT02754570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02754570 about?
NCT02754570 is a clinical study titled "The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure". The aim of this study will be to determine the effects of pilocarpine as an adjunct medication to latanoprost monotherapy at multiple intervals throughout a 24-hour period and compare these effects to latanoprost alone.
What is the current status of trial NCT02754570?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-07. Estimated completion is 2018-02-21.
What interventions are being tested in trial NCT02754570?
The interventions under investigation include: Pilocarpine (DRUG).
Who is sponsoring clinical trial NCT02754570?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.